Bajaj Healthcare cash flow

Latest FY26

Cash from operations: ₹58.1cr+168.6% on FY25
Capital spending: ₹43.3cr+275.7% on FY25
Free cash flow: ₹14.7cr+46.1% on FY25
Cash from financing: ₹24.3cr−₹6.4 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	27.5	27.9	31.4	27.4
	—	−0.2	0.0	0.0	0.0
	—	22.2	27.9	41.9	22.9
	—	0.0	0.0	−0.3	−0.2
	—	0.0	0.0	51.4	0.0
	—	−6.5	−3.9	1.1	0.0
	—	37.3	−5.0	45.0	1.4
	—	−5.1	−4.0	−87.2	−0.0
	—	−54.1	−17.8	20.4	−49.5
	—	0.0	−68.3	12.6	−47.4
	—	21.3	0.0	0.0	0.0
	—	−23.9	0.0	0.0	0.0
	—	0.0	11.0	−13.9	−6.5
	—	−0.3	−0.5	0.0	0.0
	—	0.0	12.9	0.0	0.0
	—	8.9	0.0	19.4	−21.5
	—	0.0	0.0	0.0	4.5
Cash from operating activities
	33.4	28.9	46.0	−16.7	58.2
	—	27.1	−19.8	122	−69.0
	—	56.1	26.2	105	−10.8
	—	−2.0	4.6	12.8	11.5
	—	58.1	21.6	92.3	−22.3
Cash from investing activities
	—	43.3	11.5	30.3	93.6
	—	2.9	0.1	11.3	0.5
	—	8.1	0.0	0.0	0.0
	—	0.3	0.5	0.3	0.2
	—	0.5	−3.9	7.5	−0.6
	—	−47.8	−14.8	−11.2	−93.4
Cash from financing activities
	—	52.6	150	0.0	0.0
	—	1.0	45.0	0.0	113
	—	0.7	170	51.7	−45.3
	—	3.1	0.1	0.2	0.0
	—	21.2	27.9	41.9	22.9
	—	3.2	2.8	2.8	4.1
	—	−1.1	0.0	0.0	0.0
	—	24.3	−6.4	−96.6	131
	—	34.6	0.4	−15.5	15.7
	—	34.6	0.4	−15.5	15.7
	—	—	—	2.2	17.7
Reference items
	113	105	82.4	76.3	107
	17.3%	17.2%	15.2%	16.1%	15.9%
	14.7	14.7	10.1	62.0	−116
	—	4.4	−127	−62.1	—
	₹4.38	₹4.38	₹3.00	₹18.42	−₹34.44
	71.49×	—	—	—	—
	—	3.68×	0.55×	−1.10×	−0.52×
	—	−2.0	4.6	12.8	11.5
	—	21.2	27.9	41.9	22.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

BAJAJHCARE₹312.85

Bajaj Healthcare Limited

· Pharma & Health

₹ CrorePeersTHEMISMED LINCOLN WANBURY SIGACHI AHCL ANUHPHR AMRUTANJANMcap ₹1,053 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	27.4	31.4	27.9	27.5	—
+ Impairment Loss / (Reversal)	0.0	0.0	0.0	-0.2	—
+ Finance Costs	22.9	41.9	27.9	22.2	—
+ Interest Income	-0.2	-0.3	0.0	0.0	—
+ Fair Value (Gains) / Losses	0.0	51.4	0.0	0.0	—
+ Unrealised FX (Gain) / Loss	0.0	1.1	-3.9	-6.5	—
+ Other Non-cash Items	1.4	45.0	-5.0	37.3	—
+ Other Reconciling Items	-0.0	-87.2	-4.0	-5.1	—
Changes in Working Capital
+ Inventories	-49.5	20.4	-17.8	-54.1	—
+ Trade Receivables — Current	-47.4	12.6	-68.3	0.0	—
+ Trade Receivables — Non-current	0.0	0.0	0.0	21.3	—
+ Other Financial Assets — Non-current	0.0	0.0	0.0	-23.9	—
+ Other Current Assets	-6.5	-13.9	11.0	0.0	—
+ Other Bank Balances	0.0	0.0	-0.5	-0.3	—
+ Other Financial Liabilities — Non-current	0.0	0.0	12.9	0.0	—
+ Other Current Liabilities	-21.5	19.4	0.0	8.9	—
+ Provisions — Current	4.5	0.0	0.0	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	58.2	-16.7	46.0	28.9	33.4
+ Total Adjustments (incl. Working Capital)	-69.0	121.8	-19.8	27.1	—
Cash from Operations (pre-tax)	-10.8	105.1	26.2	56.1	—
+ Income Taxes Paid	11.5	12.8	4.6	-2.0	—
Cash from Operating Activities	-22.3	92.3	21.6	58.1	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	93.6	30.3	11.5	43.3	—
+ Disp of Fixed Assets	0.5	11.3	0.1	2.9	—
+ Acq of Subsidiaries / Businesses (net)	0.0	0.0	0.0	8.1	—
+ Interest Received — Investing	0.2	0.3	0.5	0.3	—
+ Other Inflows / (Outflows) — Investing	-0.6	7.5	-3.9	0.5	—
Cash from Investing Activities	-93.4	-11.2	-14.8	-47.8	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	0.0	149.7	52.6	—
+ Proceeds from Borrowings	113.2	0.0	45.0	1.0	—
+ Repayment of Borrowings	-45.3	51.7	170.3	0.7	—
+ Payment of Lease Liabilities	0.0	0.2	0.1	3.1	—
+ Interest Paid	22.9	41.9	27.9	21.2	—
+ Dividends Paid	4.1	2.8	2.8	3.2	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	0.0	-1.1	—
Cash from Financing Activities	131.5	-96.6	-6.4	24.3	—
Net Changes in Cash (pre-FX)	15.7	-15.5	0.4	34.6	—
Net Changes in Cash	15.7	-15.5	0.4	34.6	—
Closing Cash	17.7	2.2	—	—	—
Reference Items
EBITDA	106.8	76.3	82.4	104.8	113.3
EBITDA Margin %	15.87	16.11	15.19	17.15	17.28
Free Cash Flow (CFO − Capex)	-115.9	62.0	10.1	14.7	14.7
Free Cash Flow to Equity	—	-62.1	-127.3	4.4	—
Free Cash Flow per Basic Share	-34.44	18.42	3.00	4.38	4.38
Price to Free Cash Flow	—	—	—	—	71.49
Cash Flow to Net Income	-0.52	-1.10	0.55	3.68	—
Cash Paid for Taxes	11.5	12.8	4.6	-2.0	—
Cash Paid for Interest	22.9	41.9	27.9	21.2	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.